annual total liabilities:
$33.51B-$874.00M(-2.54%)Summary
- As of today (April 18, 2025), ABT annual total liabilities is $33.51 billion, with the most recent change of -$874.00 million (-2.54%) on December 31, 2024.
- During the last 3 years, ABT annual total liabilities has fallen by -$5.66 billion (-14.45%).
- ABT annual total liabilities is now -25.78% below its all-time high of $45.15 billion, reached on December 31, 2017.
Performance
ABT Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$33.51B-$815.00M(-2.37%)Summary
- As of today (April 18, 2025), ABT quarterly total liabilities is $33.51 billion, with the most recent change of -$815.00 million (-2.37%) on December 31, 2024.
- Over the past year, ABT quarterly total liabilities has dropped by -$874.00 million (-2.54%).
- ABT quarterly total liabilities is now -25.78% below its all-time high of $45.15 billion, reached on December 31, 2017.
Performance
ABT quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ABT Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | -2.5% |
| 3 y3 years | -14.4% | -2.5% |
| 5 y5 years | -8.4% | -2.5% |
ABT Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | at low | -12.7% | +0.3% |
| 5 y | 5-year | -15.3% | at low | -15.3% | +0.3% |
| alltime | all time | -25.8% | +2034.3% | -25.8% | +2034.3% |
Abbott Laboratories Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $33.51B(-2.5%) | $33.51B(-2.4%) |
| Sep 2024 | - | $34.33B(+2.6%) |
| Jun 2024 | - | $33.46B(+0.1%) |
| Mar 2024 | - | $33.42B(-2.8%) |
| Dec 2023 | $34.39B(-8.4%) | $34.39B(-0.0%) |
| Sep 2023 | - | $34.40B(-4.3%) |
| Jun 2023 | - | $35.95B(-1.7%) |
| Mar 2023 | - | $36.56B(-2.6%) |
| Dec 2022 | $37.53B(-4.2%) | $37.53B(+1.7%) |
| Sep 2022 | - | $36.92B(-1.5%) |
| Jun 2022 | - | $37.49B(-2.3%) |
| Mar 2022 | - | $38.38B(-2.0%) |
| Dec 2021 | $39.17B(-0.9%) | $39.17B(+0.0%) |
| Sep 2021 | - | $39.16B(-0.2%) |
| Jun 2021 | - | $39.24B(+0.6%) |
| Mar 2021 | - | $39.00B(-1.4%) |
| Dec 2020 | $39.55B(+8.1%) | $39.55B(+5.6%) |
| Sep 2020 | - | $37.45B(-1.4%) |
| Jun 2020 | - | $37.98B(+4.5%) |
| Mar 2020 | - | $36.35B(-0.6%) |
| Dec 2019 | $36.59B(+0.4%) | $36.59B(+0.2%) |
| Sep 2019 | - | $36.52B(-0.0%) |
| Jun 2019 | - | $36.53B(+0.1%) |
| Mar 2019 | - | $36.48B(+0.1%) |
| Dec 2018 | $36.45B(-19.3%) | $36.45B(-10.5%) |
| Sep 2018 | - | $40.74B(+8.2%) |
| Jun 2018 | - | $37.64B(-4.2%) |
| Mar 2018 | - | $39.31B(-12.9%) |
| Dec 2017 | $45.15B(+41.3%) | $45.15B(+12.8%) |
| Sep 2017 | - | $40.03B(+1.7%) |
| Jun 2017 | - | $39.36B(+0.1%) |
| Mar 2017 | - | $39.34B(+23.1%) |
| Dec 2016 | $31.95B(+60.4%) | $31.95B(+71.8%) |
| Sep 2016 | - | $18.60B(-2.3%) |
| Jun 2016 | - | $19.04B(+1.3%) |
| Mar 2016 | - | $18.80B(-5.7%) |
| Dec 2015 | $19.92B(+1.8%) | $19.92B(-2.9%) |
| Sep 2015 | - | $20.51B(-2.3%) |
| Jun 2015 | - | $21.00B(-0.5%) |
| Mar 2015 | - | $21.11B(+7.9%) |
| Dec 2014 | $19.57B(+10.6%) | $19.57B(+0.2%) |
| Sep 2014 | - | $19.52B(+9.8%) |
| Jun 2014 | - | $17.77B(-2.2%) |
| Mar 2014 | - | $18.17B(+2.8%) |
| Dec 2013 | $17.69B(-56.2%) | $17.69B(-13.1%) |
| Sep 2013 | - | $20.34B(-0.6%) |
| Jun 2013 | - | $20.48B(+2.4%) |
| Mar 2013 | - | $20.00B(-50.5%) |
| Dec 2012 | $40.42B(+13.1%) | $40.42B(+11.8%) |
| Sep 2012 | - | $36.15B(-3.0%) |
| Jun 2012 | - | $37.29B(+1.1%) |
| Mar 2012 | - | $36.87B(+3.1%) |
| Dec 2011 | $35.75B(-5.4%) | $35.75B(+2.3%) |
| Sep 2011 | - | $34.94B(-1.7%) |
| Jun 2011 | - | $35.53B(-3.8%) |
| Mar 2011 | - | $36.93B(-2.3%) |
| Dec 2010 | $37.81B(+28.1%) | $37.81B(+5.3%) |
| Sep 2010 | - | $35.89B(+7.5%) |
| Jun 2010 | - | $33.39B(+3.2%) |
| Mar 2010 | - | $32.35B(+9.6%) |
| Dec 2009 | $29.52B(+18.5%) | $29.52B(+3.7%) |
| Sep 2009 | - | $28.47B(+2.8%) |
| Jun 2009 | - | $27.71B(+0.9%) |
| Mar 2009 | - | $27.45B(+10.3%) |
| Dec 2008 | $24.90B(+13.5%) | $24.90B(+11.1%) |
| Sep 2008 | - | $22.41B(-10.8%) |
| Jun 2008 | - | $25.11B(+8.3%) |
| Mar 2008 | - | $23.20B(+5.8%) |
| Dec 2007 | $21.94B(-0.9%) | $21.94B(-0.4%) |
| Sep 2007 | - | $22.01B(+0.9%) |
| Jun 2007 | - | $21.82B(-0.7%) |
| Mar 2007 | - | $21.97B(-0.7%) |
| Dec 2006 | $22.12B | $22.12B(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $17.67B(-6.4%) |
| Jun 2006 | - | $18.88B(+34.0%) |
| Mar 2006 | - | $14.09B(-4.3%) |
| Dec 2005 | $14.73B(+2.0%) | $14.73B(+1.1%) |
| Sep 2005 | - | $14.57B(+8.4%) |
| Jun 2005 | - | $13.44B(-8.5%) |
| Mar 2005 | - | $14.68B(+1.6%) |
| Dec 2004 | $14.44B(+11.4%) | $14.44B(-1.1%) |
| Sep 2004 | - | $14.61B(-1.7%) |
| Jun 2004 | - | $14.86B(+2.2%) |
| Mar 2004 | - | $14.54B(+12.1%) |
| Dec 2003 | $12.97B(-4.6%) | $12.97B(-9.3%) |
| Sep 2003 | - | $14.29B(+2.1%) |
| Jun 2003 | - | $14.00B(+3.6%) |
| Mar 2003 | - | $13.51B(-0.6%) |
| Dec 2002 | $13.59B(-4.5%) | $13.59B(+3.7%) |
| Sep 2002 | - | $13.11B(-0.4%) |
| Jun 2002 | - | $13.16B(-1.2%) |
| Mar 2002 | - | $13.32B(-6.4%) |
| Dec 2001 | $14.24B(+112.1%) | $14.24B(+1.3%) |
| Sep 2001 | - | $14.05B(+3.6%) |
| Jun 2001 | - | $13.56B(-2.3%) |
| Mar 2001 | - | $13.88B(+106.8%) |
| Dec 2000 | $6.71B(-4.7%) | $6.71B(+0.7%) |
| Sep 2000 | - | $6.67B(-1.7%) |
| Jun 2000 | - | $6.78B(-4.3%) |
| Mar 2000 | - | $7.09B(+0.6%) |
| Dec 1999 | $7.04B(-6.2%) | $7.04B(+2.0%) |
| Sep 1999 | - | $6.90B(+3.0%) |
| Jun 1999 | - | $6.71B(-7.6%) |
| Mar 1999 | - | $7.25B(-3.4%) |
| Dec 1998 | $7.51B(+6.3%) | $7.51B(+3.8%) |
| Sep 1998 | - | $7.23B(-2.0%) |
| Jun 1998 | - | $7.37B(+5.8%) |
| Mar 1998 | - | $6.97B(-1.3%) |
| Dec 1997 | $7.06B(+12.0%) | $7.06B(+4.9%) |
| Sep 1997 | - | $6.73B(+3.7%) |
| Jun 1997 | - | $6.50B(+2.4%) |
| Mar 1997 | - | $6.34B(+0.6%) |
| Dec 1996 | $6.31B(+25.7%) | $6.31B(+5.9%) |
| Sep 1996 | - | $5.96B(+0.7%) |
| Jun 1996 | - | $5.91B(+24.6%) |
| Mar 1996 | - | $4.75B(-5.4%) |
| Dec 1995 | $5.02B(+12.1%) | $5.02B(+4.6%) |
| Sep 1995 | - | $4.79B(+1.0%) |
| Jun 1995 | - | $4.75B(+2.7%) |
| Mar 1995 | - | $4.62B(+3.3%) |
| Dec 1994 | $4.47B(+11.5%) | $4.47B(+1.7%) |
| Sep 1994 | - | $4.40B(+4.0%) |
| Jun 1994 | - | $4.23B(+5.8%) |
| Mar 1994 | - | $4.00B(-0.4%) |
| Dec 1993 | $4.01B(+11.7%) | $4.01B(+1.9%) |
| Sep 1993 | - | $3.94B(+3.3%) |
| Jun 1993 | - | $3.81B(+3.1%) |
| Mar 1993 | - | $3.70B(+2.9%) |
| Dec 1992 | $3.59B(+17.7%) | $3.59B(+1.6%) |
| Sep 1992 | - | $3.54B(+12.0%) |
| Jun 1992 | - | $3.16B(+1.7%) |
| Mar 1992 | - | $3.11B(+1.8%) |
| Dec 1991 | $3.05B(+11.8%) | $3.05B(+6.8%) |
| Sep 1991 | - | $2.86B(-0.2%) |
| Jun 1991 | - | $2.86B(+0.9%) |
| Mar 1991 | - | $2.84B(+3.9%) |
| Dec 1990 | $2.73B(+28.4%) | $2.73B(-8.5%) |
| Sep 1990 | - | $2.98B(+11.6%) |
| Jun 1990 | - | $2.67B(+10.1%) |
| Mar 1990 | - | $2.43B(+14.2%) |
| Dec 1989 | $2.13B(-10.0%) | $2.13B(-10.0%) |
| Dec 1988 | $2.36B(+3.0%) | $2.36B(+3.0%) |
| Dec 1987 | $2.29B(+9.8%) | $2.29B(+9.8%) |
| Dec 1986 | $2.09B(+30.6%) | $2.09B(+30.6%) |
| Dec 1985 | $1.60B(+1.8%) | $1.60B(+1.8%) |
| Dec 1984 | $1.57B | $1.57B |
FAQ
- What is Abbott Laboratories annual total liabilities?
- What is the all time high annual total liabilities for Abbott Laboratories?
- What is Abbott Laboratories annual total liabilities year-on-year change?
- What is Abbott Laboratories quarterly total liabilities?
- What is the all time high quarterly total liabilities for Abbott Laboratories?
- What is Abbott Laboratories quarterly total liabilities year-on-year change?
What is Abbott Laboratories annual total liabilities?
The current annual total liabilities of ABT is $33.51B
What is the all time high annual total liabilities for Abbott Laboratories?
Abbott Laboratories all-time high annual total liabilities is $45.15B
What is Abbott Laboratories annual total liabilities year-on-year change?
Over the past year, ABT annual total liabilities has changed by -$874.00M (-2.54%)
What is Abbott Laboratories quarterly total liabilities?
The current quarterly total liabilities of ABT is $33.51B
What is the all time high quarterly total liabilities for Abbott Laboratories?
Abbott Laboratories all-time high quarterly total liabilities is $45.15B
What is Abbott Laboratories quarterly total liabilities year-on-year change?
Over the past year, ABT quarterly total liabilities has changed by -$874.00M (-2.54%)